Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Riddle

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Reviews in Endocrine & Metabolic Disorders|November 18, 2003
Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoringElizabeth Stephens, Matthew Riddle
Clinical Toxicology (Philadelphia, Pa.)|September 19, 2019
Successful treatment of brown widow spider envenomation with <i>Latrodectus mactans</i> antivenomMatthew Riddle, Shaun Carstairs
Postgraduate Medicine|April 26, 2016
Increasing Patient Acceptance and Adherence Toward InsulinMatthew Riddle, Anne Peters, Martha Funnell
Diabetes Technology & Therapeutics|August 25, 2009
Reconsideration of severe hypoglycemic events in the treat-to-target trialGeorge Dailey, Poul Strange, Matthew Riddle
International Journal of Epidemiology|October 13, 2009
Causal thinking and complex system approaches in epidemiologySandro Galea, Matthew Riddle, George A Kaplan
Diabetes/Metabolism Research and Reviews|February 23, 2007
When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?Denis Raccah, Reinhard G Bretzel, David Owens, et al.
Diabetes Care|October 27, 2011
Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetesMatthew Riddle, Guillermo Umpierrez, Andres DiGenio, et al.
Diabetes Care|May 23, 2013
Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilanceWilliam T Cefalu, Julio Rosenstock, Robert R Henry, et al.
Environmental Science & Technology|November 3, 2015
Understanding Variability To Reduce the Energy and GHG Footprints of U.S. Ethylene ProductionYuan Yao, Diane J Graziano, Matthew Riddle, et al.
Diabetes Care|June 9, 2009
Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetesMatthew Riddle, Richard Pencek, Supoat Charenkavanich, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Reviews in Endocrine & Metabolic Disorders|November 18, 2003
Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoringElizabeth Stephens, Matthew Riddle
Clinical Toxicology (Philadelphia, Pa.)|September 19, 2019
Successful treatment of brown widow spider envenomation with <i>Latrodectus mactans</i> antivenomMatthew Riddle, Shaun Carstairs
Postgraduate Medicine|April 26, 2016
Increasing Patient Acceptance and Adherence Toward InsulinMatthew Riddle, Anne Peters, Martha Funnell
Diabetes Technology & Therapeutics|August 25, 2009
Reconsideration of severe hypoglycemic events in the treat-to-target trialGeorge Dailey, Poul Strange, Matthew Riddle
International Journal of Epidemiology|October 13, 2009
Causal thinking and complex system approaches in epidemiologySandro Galea, Matthew Riddle, George A Kaplan
Diabetes/Metabolism Research and Reviews|February 23, 2007
When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?Denis Raccah, Reinhard G Bretzel, David Owens, et al.
Diabetes Care|October 27, 2011
Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetesMatthew Riddle, Guillermo Umpierrez, Andres DiGenio, et al.
Diabetes Care|May 23, 2013
Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilanceWilliam T Cefalu, Julio Rosenstock, Robert R Henry, et al.
Environmental Science & Technology|November 3, 2015
Understanding Variability To Reduce the Energy and GHG Footprints of U.S. Ethylene ProductionYuan Yao, Diane J Graziano, Matthew Riddle, et al.
Diabetes Care|June 9, 2009
Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetesMatthew Riddle, Richard Pencek, Supoat Charenkavanich, et al.
Pageof 3